医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响

doi:10.6040/j.issn.1673-3770.0.2023.383

摘要/Abstract

摘要： 目的比较医用透明质酸钠(medical sodium hyaluronate, HA)和平衡盐溶液(balance salt solution, BSS)在增殖性糖尿病视网膜病变(proliferative diabetic retinopathy, PDR)微创玻璃体手术(minimally invasive vitreorentinal surgery, MIVS)中对眼表保护的效果及对泪膜稳定性的影响。方法临床随机对照试验:选取PDR患者40例40眼,采用抗血管内皮生长因子(vascular endothelial growth factor, VEGF)药物辅助的MIVS治疗。按照随机数字表法将患者分为HA组(20例20眼)、BSS组(20例20眼)。每组术中分别应用HA和BSS保持眼表湿润。分别于术前、术后1、7、30 d行眼表疾病指数量表(ocular surface disease index, OSDI)、非侵入性泪膜破裂时间(non-invasive tear break-up time, NITBUT)、基础泪液分泌试验(Schirmer Ⅰtest, SⅠt)、角膜荧光染色(corneal fluorescein staining, CFS)及术中角膜透明度的检测和评估。结果 OSDI组间比较,术后各个时间点HA组优于BSS组(P_{1 d}=0.001、P_{7 d}<0.001、P_{30 d}=0.001);组内比较,HA组术后1 d较术前受损(P_HA1d<0.001),术后30 d优于术前(P_HA30d=0.002),BSS组术后1 d、7 d较术前受损(P_BSS1d<0.001、P_BSS7d<0.001)。SⅠt2组组内比较,HA组、BSS组术后1、7 d较术前受损(P_HA1d<0.001、P_HA7d<0.001、P_BSS1d<0.001、P_BSS7d<0.001),HA组术后30 d优于术前(P_HA30d<0.001)。NITBUT组间比较,术后7 d HA组优于BSS组(P_7d<0.001);组内比较,HA组、BSS组术后7 d、30 d较术前均受损(P_HA7d<0.001、P_HA30d=0.027、P_BSS7d<0.001,P_BSS30d=<0.001)。CFS组间比较,术后1 d HA组优于BSS组(P_{1 d}<0.001);组内比较,HA组、BSS组术后1、7 d较术前受损(P_HA1d<0.001、P_HA7d<0.001、P_BSS1d<0.001、P_BSS7d<0.001),BSS组术后30 d较术前仍受损(P_BSS30d=0.024)。术中角膜透明度HA组优于BSS组(P=0.038)。结论在增殖性糖尿病视网膜病变微创玻璃体手术中应用医用透明质酸钠保护眼表,可减轻围手术期眼表损伤,增加术中的可视性,缩短术后泪膜恢复时间。

关键词: 玻璃体视网膜手术, 微创, 增殖性糖尿病视网膜病变, 透明质酸钠, 平衡盐溶液, 泪膜

Abstract: Objective To evaluate the protective effect of the ocular surface of medical sodium hyaluronate(HA)and balanced salt solution(BSS)in patients with proliferative diabetic retinopathy(PDR)performing minimally invasive vitreorentinal surgery(MIVS). Methods A retrospective case-controlled study was designed. Forty patients(40 eyes)with PDR performed with anti-vascular endothelial growth factor-assisted MIVS surgery were enrolled in this study, randomly divided into the HA group ［20 cases(20 eyes)］ and the BSS group ［20 cases(20 eyes)］. During surgery, HA and BSS were applied to keep the ocular surface moist according to grouping. Ocular surface disease index(OSDI), Schirmer Ⅰ test(SⅠt), non-invasive tear film break-up time(NITBUT), corneal fluorescein staining(CFS)and corneal transparency during the surgery were performed preoperatively and at 1, 7 and 30 days postoperatively. Results The OSDI of the HA group was superior to that of the BSS group at all postoperative time points(P_{1 d}=0.001、P_{7 d}<0.001、P_{30 d}=0.001). Intragroup comparison showed that the HA group was more damaged 1 day after surgery than preoperative(P_HA1d<0.001), and 30 days after surgery was better than preoperative(P_HA30d=0.002), and the BSS group was more damaged 1 day and 7 days after surgery than preoperative(P_BSS1d<0.001, P_BSS7d<0.001). Intragroup comparison in the SⅠt 2 group showed that the damage in the HA group and the BSS group was worse than preoperative(P_HA1d<0.001, P_HA7d<0.001, P_BSS1d<0.001, P_BSS7d<0.001), and damage in the HA group was better than preoperative(P_HA30d<0.001). Compared to the NITBUT group, the 7 d HA group was better than the BSS group(P_{7 d}<0.001). Intragroup comparison showed that the damage to the HA group and the BSS group was greater at 7 and 30 days postoperatively than preoperatively(P_HA7d<0.001, P_HA30d=0.027, P_BSS7d<0.001, P_BSS30d=<0.001). Among the CFS groups, the HA group was better than the BSS group on 1d postoperatively(P_{1 d}<0.001). Intragroup comparison showed that the damage in the HA group and the BSS group was greater than before the operation(P_HA1d<0.001, P_HA7d<0.001, P_BSS1d<0.001, P_BSS7d<0.001), and the damage in the BSS group was still greater than before the operation and 30 days after the operation(P_BSS30d=0.024). Intraoperative corneal transparency in the HA group was better than that in the BSS group(P=0.038). Conclusion Compared to BSS, HA has better protection of the ocular surface during MIVS in patients with PDR, remains the corneal transparency during surgery and shortens the repair time of the ocular surface tissue after surgery.

Key words: Vitreorentinal surgery, Minimally invasive, Proliferative diabetic retinopathy, Sodium hyaluronate, Balance salt solution, Tear film

中图分类号:

R777

辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.

XIN Meng, JI Fang, DAI Chunhua, ZHANG Jing, LIU Shu. Effect of sodium hyaluronate and balanced salt solution on ocular surface protection during minimally invasive vitreorentinal surgery[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 58-65.

参考文献

[1] 中国老年医学学会老年内分泌代谢分会, 中国老年保健医学研究会老年内分泌与代谢分会, 北京医学奖励基金会老年医学专业委员会, 等. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中国糖尿病杂志, 2022, 30(1): 2-51. doi: 10. 3969/j. issn. 1006-6187. 2022. 01. 002
[2] Association AD. 11. microvascular complications and foot care: Standards of medical care in diabetes-2021[J]. Diabetes Care, 2021, 44(1): 151-167. doi:10.2337/dc21-S011
[3] 陆菊明. 《中国2型糖尿病防治指南(2020年版)》读后感[J]. 中华糖尿病杂志, 2021, 13(4): 301-304. doi:10.3760/cma.j.cn115791-20210307-00135 LU Juming. Reaction to guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)[J]. Chinese Journal of Diabetes Mellitus, 2021, 13(4): 301-304. doi:10.3760/cma.j.cn115791-20210307-00135
[4] 中华医学会眼科学分会眼底病学组, 中国医师协会眼科医师分会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2022年)——基于循证医学修订[J]. 中华眼底病杂志, 2023, 39(2):99-124. doi: 10.3760/cma.j.cn511434-20230110-00018. Fundus disease group of ophthalmological society of Chinese medical association, fundus disease group of ophthalmologist Branch of Chinese Medical Doctor Association,Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China(2022)[J]. Chin J Ocul Fundus Dis, 2023, 39(2):99-124. doi: 10.3760/cma.j.cn511434-20230110-00018
[5] 向英, 李霞, 宋秀胜. 糖尿病眼表病变的研究进展[J]. 国际眼科纵览, 2020, 44(4): 245-249. doi:10.3760/cma.j.issn.1673-5803.2020.04.006 XIANG Ying, LI Xia, SONG Xiusheng. Research progress in diabetic ocular surface lesions[J]. International Review of Ophthalmology, 2020, 44(4): 245-249. doi:10.3760/cma.j.issn.1673-5803.2020.04.006
[6] 中华医学会眼科学分会白内障及人工晶体学组. 中国糖尿病患者白内障围手术期管理策略专家共识(2020年)[J]. 中华眼科杂志, 2020, 56(5): 337-342. doi:10.3760/cma.j.cn112142-20191106-00559
[7] 亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识:眼手术相关性干眼(2021年)[J]. 中华眼科杂志, 2021, 57(8): 564-572. doi:10.3760/cma.j.cn112142-20210429-00196 China branch of asian dry eye society, ocular surface and tear disease group of ophthalmology committee of cross?straits medicine exchange association, ocular surface and dry eye group of Chinese ophthalmologist association..Expert consensus on dry eye in China: dry eye related to eye surgery(2021)[J]. Chinese Journal of Ophthalmology, 2021, 57(8): 564-572. doi:10.3760/cma.j.cn112142-20210429-00196
[8] 杜兴, 盛艳娟, 李姗姗, 等. 玻璃体切除术中应用透明质酸钠对泪膜保护作用的研究[J]. 中华眼外伤职业眼病杂志, 2022, 44(7): 534-540. doi:10.3760/cma.j.cn116022-20220115-00018 DU Xing, SHENG Yanjuan, LI Shanshan, et al. Protective effect of sodium hyaluronate on tear film during vitrectomy[J]. Chinese Journal of ocular trauma and occupational eye disease, 2022, 44(7): 534-540. doi:10.3760/cma.j.cn116022-20220115-00018
[9] 王伟, 李甦雁, 张正培, 等. 角膜保护剂与平衡盐溶液在增生性糖尿病视网膜病变微创玻璃体手术中对眼表保护作用的比较[J]. 中华实验眼科杂志, 2021, 39(11): 982-988. doi:10.3760/cma.j.cn115989-20200430-00303 WANG Wei, LI Suyan, ZHANG Zhengpei, et al. Comparison of the protective effect of corneal protectant and balanced salt solution on the ocular surface during minimally invasive vitreous surgery for proliferative diabetic retinopathy[J]. Chinese Journal of Experimental Ophthalmology, 2021, 39(11): 982-988. doi:10.3760/cma.j.cn115989-20200430-00303
[10] Chen SN, Chen SJ, Wu TT, et al. Refining vitrectomy for proliferative diabetic retinopathy[J]. Graefes Arch Clin Exp Ophthalmol, 2023, 261(12): 3659-3670. doi:10.1007/s00417-023-06134-w
[11] 封艳, 潘玲, 吴欲晓, 等. 不同浓度聚维酮碘二次冲洗法对白内障手术结膜囊消毒效果的评价[J]. 国际眼科杂志, 2019, 19(8): 1403-1405. doi:10.3980/j.issn.1672-5123.2019.8.33 FENG Yan, PAN Ling, WU Yuxiao, et al. Disinfection effects of secondary irrigation with different concentrations of povidone-iodine on conjunctival sac cataract surgery in[J]. International Eye Science, 2019, 19(8): 1403-1405. doi:10.3980/j.issn.1672-5123.2019.8.33
[12] Hwang GE, Lee ES, Kim HD. Influence of vitreoretinal surgery on ocular surface dynamics using keratograph 5M[J]. Korean J Ophthalmol, 2023, 37(5): 417-428. doi:10.3341/kjo.2023.0061
[13] 谢立信, 姚瞻, 黄钰森, 等. 超声乳化白内障吸除术后角膜内皮细胞损伤和修复的研究[J]. 中华眼科杂志, 2004, 40(2): 90-93. doi:10.3760/j: issn: 0412-4081.2004.02.006 XIE Lixin, YAO Zhan, HUANG Yusen, et al. Corneal endothelial damage and its repair after phacoemulsification[J]. Chinese Journal of Ophthalmology, 2004, 40(2): 90-93. doi:10.3760/j: issn: 0412-4081.2004.02.006
[14] 王娇娇, 李苗, 宋宗明. 糖尿病视网膜病变的机制和细胞模型研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 93-99. doi: 10.6040/j.issn.1673-3770.0.2021.203 WANG Jiaojiao, LI Miao, SONG Zongming. Progress in diabetic retinopathy mechanisms and cellular models[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 93-99. doi: 10.6040/j.issn.1673-3770.0.2021.203
[15] Korhonen A, Gucciardo E, Lehti K, et al. Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement[J]. Sci Rep, 2021, 11(1): 18810. doi:10.1038/s41598-021-97970-5
[16] Ribeiro L, Oliveira J, Kuroiwa D, et al. Advances in vitreoretinal surgery[J]. J Clin Med, 2022, 11(21): 6428. doi:10.3390/jcm11216428
[17] 吕林, 陈士达. 微创玻璃体手术时代:糖尿病视网膜病变手术的新认识[J]. 中华眼底病杂志, 2022, 38(1): 1-5. doi:10.3760/cma.j.cn511434-20211206-00681 LV Lin, CHEN Shida. The era of minimally invasive vitreous surgery: new insights into diabetic retinopathy surgery[J]. Chinese Journal of Ocular Fundus Diseases, 2022, 38(1): 1-5. doi:10.3760/cma.j.cn511434-20211206-00681
[18] Berrocal MH, Acaba-Berrocal L. Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review of current literature[J]. Curr Opin Ophthalmol, 2021, 32(3): 203-208. doi: 10. 1097/ICU.0000000000000760
[19] Zheng WB, Chen SD, Ding XH, et al. Microinvasive pars Plana vitrectomy versus panretinal photocoagulation in the treatment of severe non-proliferative diabetic retinopathy(the VIP study): study protocol for a randomised controlled trial[J]. BMJ Open, 2021, 11(2): e043371. doi:10.1136/bmjopen-2020-043371
[20] 徐格致, 王克岩. 重基础,与时进,不断提高增生型糖尿病视网膜病变的手术疗效[J]. 中华眼底病杂志, 2021, 37(1): 5-9. doi:10.3760/cma.j.cn511434-20210101-00001 XU Gezhi, WANG Keyan. Improving surgical efficacy of proliferative diabetic retinopathy continuously by paying attention to the basis and keeping pace with the times[J]. Chinese Journal of Ocular Fundus Diseases, 2021, 37(1): 5-9. doi:10.3760/cma.j.cn511434-20210101-00001
[21] WANG Dogyue, ZHAO Xinyu, ZHANG Wenfei, et al. Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis[J]. Sci Rep, 2020, 10(1): 18880.doi: 10.1038/s41598-020-75896-8
[22] Qu JF, Chen XJ, Liu QH, et al. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: a randomized controlled trial[J]. Front Public Health, 2023, 10: 1067670. doi:10.3389/fpubh.2022.1067670
[23] Zhou QJ, Yang LL, Wang Q, et al. Mechanistic investigations of diabetic ocular surface diseases[J]. Front Endocrinol, 2022, 13: 1079541. doi:10.3389/fendo.2022.1079541
[24] 刘廷, 孙大鹏, 李东芳, 等. 活体共聚焦显微镜观察2型糖尿病角膜病变及定量分析研究 [J]. 中华眼科杂志, 2020, 56(10): 754-760. doi:10.3760/cma.j.cn112142-20200108-00012 LIU Ting, SUN Dapeng, LI Dongfang, et al. Observation and quantification of diabetic keratopathy in type 2 diabetes patients using in vivo laser confocal microscopy[J]. Chin J Ophthalmol, 2020, 56(10): 754-760. doi:10.3760/cma.j.cn112142-20200108-00012
[25] 蒋佳倩, 尹一忠, 陈放, 等. 玻璃体切除术对糖尿病性视网膜病变患者眼表及泪液成分的影响[J]. 中华眼外伤职业眼病杂志, 2023, 45(4): 302-309. doi:10.3760/cma.j.cn116022-20221220-00473 JIANG Jiaqian, YIN Yizhong, CHEN Fang, et al. Effect of vitrectomy on ocular surface and tear composition in patients with diabetes retinopathy[J]. Chinese Journal of ocular trauma and occupational eye disease, 2023, 45(4): 302-309. doi:10.3760/cma.j.cn116022-20221220-00473
[26] 万磊, 周庆军, 谢立信. 糖尿病相关干眼发病机制的研究进展[J]. 中华眼科杂志, 2022, 58(12): 1099-1105. doi:10.3760/cma.j.cn112142-20220503-00227 WAN Lei, ZHOU Qingjun, XIE Lixin. Research progress on the pathogenesis of diabetes-related dry eye[J]. Chinese Journal of Ophthalmology, 2022, 58(12): 1099-1105. doi:10.3760/cma.j.cn112142-20220503-00227
[27] Du X, Yang Z, Guo YY, et al. Analysis of risk factors for dry eye disease and effect of diquafosol sodium ophthalmic solution on the tear film after vitrectomy in patients with type 2 diabetes mellitus: a preliminary study[J]. Int Ophthalmol, 2023, 43(6): 1849-1859. doi:10.1007/s10792-022-02584-z
[28] Faustino-Barros JF, Saranzo Sant’Ana AM, Dias LC, et al. Distinct inflammatory and oxidative effects of diabetes mellitus and hypothyroidism in the lacrimal functional unit[J]. Int J Mol Sci, 2023, 24(8): 6974. doi:10.3390/ijms24086974
[29] Pflugfelder SC, Stern ME. Biological functions of tear film[J]. Exp Eye Res, 2020, 197: 108115. doi:10.1016/j.exer.2020.108115
[30] Yu FS X, Lee PSY, Yang LL, et al. The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas[J]. Prog Retin Eye Res, 2022, 89: 101039. doi:10.1016/j.preteyeres.2021.101039
[31] Mangoli MV, Bubanale SC, Bhagyajyothi BK, et al. Dry eye disease in diabetics versus non-diabetics: Associating dry eye severity with diabetic retinopathy and corneal nerve sensitivity[J]. Indian J Ophthalmol, 2023, 71(4): 1533-1537. doi:10.4103/IJO.IJO_2680_22
[32] Abatangelo G, Vindigni V, Avruscio G, et al. Hyaluronic acid: redefining its role[J]. Cells, 2020, 9(7): 1743. doi:10.3390/cells9071743
[33] Mikalauskiene L, Grzybowski A, Zemaitiene R. Ocular surface changes associated with ophthalmic surgery[J]. J Clin Med, 2021, 10(8): 1642. doi:10.3390/jcm10081642
[34] Mani R, Shobha PS, Thilagavathi S, et al. Altered mucins and aquaporins indicate dry eye outcome in patients undergoing Vitreo-retinal surgery[J]. PLoS One, 2020, 15(5): e0233517. doi:10.1371/journal.pone.0233517
[35] Ratra D, Mohan S, Ratra V, et al. Molecular and genetic changes in the tear film following microincisional vitrectomy surgery[J]. Indian J Ophthalmol, 2023, 71(4): 1664-1665. doi:10.4103/ijo.ijo_2677_22
[36] Xiao W, Huang PC. Effects of the preoperative use of artificial tears combined with recombinant bovine basic fibroblast growth factor on cataract patients complicated with dry eyes[J]. Arq Bras Oftalmol, 2022, 87(2): 0539. doi:10.5935/0004-2749.2021-0539

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed